Selected article for: "effective response and virus risk"
Author: Perez, Annalisa; Naljayan, Mihran; Shuja, Imran; Florea, Andre; Reisin, Efrain
Title: Hypertension, Obesity, and COVID-19: a Collision of Pandemics
  • Cord-id: 1n6hbs18
  • Document date: 2021_6_29
    • ID: 1n6hbs18
    Snippet: PURPOSE OF REVIEW: To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these pa
    Document: PURPOSE OF REVIEW: To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also been seen historically in other viral illnesses. SUMMARY: Understanding the mechanisms behind the associations between COVID-19, hypertension, and obesity is important in developing effective targeted therapies and monitoring vaccine response and efficacy. More research is needed to apply our growing knowledge of the pathophysiology of COVID-19, hypertension, and obesity to prevention and treatment. Interventions focusing on lifestyle modification in managing hypertension and obesity can potentially have a positive impact on containing this pandemic and future viral illness outbreaks.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and adipose tissue: 1
    • ace inhibitor and lung effect: 1, 2
    • ace inhibitor and lung epithelium: 1, 2
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace inhibitor and lung tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and local spread: 1
    • acute ards respiratory distress syndrome and low number: 1
    • acute ards respiratory distress syndrome and lung ability: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and lung capacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11